Covid-19 Ohio
|
||
|
Here’s the latest news:
· Italy extends lockdown to May 3 · Gilead Sciences antiviral shows promising signs · Trump hints at withholding WHO funds |
In From the Cold |
With meteorologists forecasting a blast of cold weather that will sweep across most of the U.S. this weekend, it’s reasonable to feel like the winter will never end. The same goes for the coronavirus outbreak that landed on America’s shores less than three seemingly interminable months ago.
But as the earth circles the sun, warm weather will inevitably arrive. The question is what effect higher temperatures will have on the new virus, a member of the coronavirus family that is known to have a seasonal component. While most people had probably never heard of a coronavirus until the Covid-19 outbreak, almost everyone has had intimate experience with them. Four or five members of the virus family can cause ailments ranging from the common cold to mild respiratory ailments. But SARS-CoV-2 thus far has seemed nothing like its close relatives. It has killed more than 100,000 people around the world. Whether it also has a seasonal component is still to be seen. The answer will have a lasting influence on how the current outbreak plays out and whether we see it again. Infectious disease experts say the complete lack of protection against a virus that’s never been seen before means even if it doesn’t spread as efficiently in warm, humid air, infections will continue as the temperature rises. Whether those who recover from their illnesses have lasting immunity, unlike with common coronaviruses, and whether the disease rebounds with cooler weather are still unknown. The answers have implications for how effective any vaccine will prove to be.—Michelle Fay Cortez |
Track the virus |
Map the outbreak around the world, and track Covid-19’s spread in the U.S. |
Sponsor Content by the Blue Cross and Blue Shield Association
Blue Cross and Blue Shield companies are enhancing access to care during the coronavirus outbreak by eliminating key costs for treatment and testing, waiving prior-authorization, expanding telehealth and increasing access to prescriptions. Learn more.
What you should read |
Run the Trump Playbook in Reverse
Bloomberg Opinion’s Joe Nocera on how to prepare for the next pandemic. |
Heart Incidents Linked to Drug Trump Promoted
U.S. has stockpiled millions of hydroxychloroquine doses. |
How to Make a Faster Vaccine
Bloomberg Opinion’s Max Nisen on the making of an inoculation. |
Apple, Google Bring Contact-Tracing to Billions
Users will be alerted if they were close to infected person. |
Illinois Bends Virus Curve Faster Than Hotspots
Confirmed cases doubling more slowly than in New York, Rush says. |
Know someone else who would like this newsletter? Have them sign up here.
Have any questions, concerns, or news tips on Covid-19 news? Get in touch or help us cover the story. Like this newsletter? Subscribe for unlimited access to trusted, data-based journalism in 120 countries around the world and gain expert analysis from exclusive daily newsletters, The Bloomberg Open and The Bloomberg Close. |